GD-15

N/A

Report date: 2023/05/17 09:39:26
NME

Base Information

Drug NameGD-15
Drug Alias NameGD-15
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeukemia, Myeloid, AcuteLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTianjin Gudui Biopharma Tech Inc
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Gudui Biopharma Tech Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, AcuteLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A